Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Role of Adenosine A2A Receptor in the Regulation of Gastric Somatostatin Release

Linda Yip and Yin Nam Kwok
Journal of Pharmacology and Experimental Therapeutics May 2004, 309 (2) 804-815; DOI: https://doi.org/10.1124/jpet.103.061986
Linda Yip
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yin Nam Kwok
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Adenosine has been demonstrated to inhibit gastric acid secretion. In the rat stomach, this inhibitory effect may be mediated indirectly by increasing the release of somatostatin-like immunoreactivity (SLI). Results show that adenosine analogs augmented SLI release in the isolated vascularly perfused rat stomach. The rank order of potency of the analogs in stimulating SLI release was 2-p-(2-carboxyethyl)phenethylamino-5′-N-ethylcarboxamidoadenosine (CGS 21680) ≈ 5′-N-ethylcarboxamidoadenosine > 2-chloroadenosine > R-(-)-N6-(2-phenylisopropyl)adenosine >1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-β-d-ribofuranuronamide > N6-cyclopentyladenosine ≈ N6-cyclohexyladenosine > S-(+)-N6-(2-phenylisopropyl) adenosine, suggesting the involvement of the A2A receptor. In agreement, 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a] [1,3,5]triazin-5-ylamino]ethyl)phenol (ZM 241385), an A2A receptor antagonist, was shown to abolish the adenosine- and CGS 21680-stimulated SLI release. Immunohistochemical studies reveal the presence of A2A receptor immunoreactivity on the gastric plexi and mucosal D-cells, but not on parietal cells and G-cells, suggesting that adenosine may act directly on D-cells or indirectly on the gastric plexi to augment SLI release. The present study also demonstrates that the structure of the mucosal A2A receptor is identical to that in the rat brain, and that alternative splicing of this gene does not occur. A real-time reverse transcription-polymerase chain reaction assay has also been established to quantify the levels of A2A receptor mRNA. Results show that gastric tissues contained significantly lower levels of A2A receptor mRNA compared with the striatum. The lowest level was detected in the mucosa. In conclusion, adenosine may act on A2A receptors to augment SLI release and consequently control gastric acid secretion.

Footnotes

  • This work was supported by the Canadian Apoptosis Research Foundation Society, Canada Foundation for Innovation, Wah Sheung Fund, and the former British Columbia Health Research Foundation. L.Y. was supported by the Cordula and Gunter Paetzold Fellowship and the University of British Columbia Graduate Fellowship. A portion of this work was included in L.Y.'s Ph.D. dissertation entitled, Adenosine A1 and A2A Receptors in the Rat Stomach: Biological Actions, Cellular Localization, Structure, and Gene Expression. Citation of meeting abstracts where part of this work was previously presented: Kwok YN and Hui J (1992) Effect of selective adenosine A1 and A2 analogs on the release of gastric somatostatin-like immunoreactivity. Regul Pept40:189; Kwok YN (1994) Purinergic control of release of somatostatin in the rat stomach. Pathophysiol Suppl1:218; Yip L and Kwok Y (2002) Gastric A1 and A2A receptors: cellular localization, gene sequence and gene expression levels. Drug Dev Res56:551; and Yip L, Leung CH, and Kwok YN (2003) Cellular localization of adenosine A1 and A2A receptors in the rat stomach. FASEB J17:A40.

  • DOI: 10.1124/jpet.103.061986.

  • ABBREVIATIONS: ADA, adenosine deaminase; SLI, somatostatin-like immunoreactivity; IR, immunoreactivity; RT-PCR, reverse transcription-polymerase chain reaction; BSA, bovine serum albumin; RIA, radioimmunoassay; 2-CA, 2-chloroadenosine; CPA, N6-cyclopentyladenosine; CGS 21680, 2-p-(2-carboxyethyl)phenethylamino-5′N-ethylcarboxamidoadenosine; CHA, 5′-N6-cyclohexyladenosine; NECA, N-ethylcarboxamidoadenosine; R-PIA, R(-)-N6-(2-phenylisopropyl)adenosine; S-PIA, (S)-N6-(2-phenylisopropyl)adenosine; IB-MECA, 1-deoxy-1-[6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-N-methyl-β-d-ribofuranuronamide; DPCPX, 8-cyclopentyl-1,3-dipropylxanthine; ZM 241385, 4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol; ENHA, erythro-9-(2-hydroxy-3-nonyl)adenine hydrochloride; DMSO, dimethyl sulfoxide; PBS, phosphate-buffered saline; A2AR-IR, A2A receptor-immunoreactivity; PGP 9.5, protein gene product 9.5; VWF, von Willebrand's factor; bp, base pair(s); UNG, uracil-N-glycosylase; CT, threshold cycle.

    • Received October 22, 2003.
    • Accepted January 16, 2004.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 309 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 309, Issue 2
1 May 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Role of Adenosine A2A Receptor in the Regulation of Gastric Somatostatin Release
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Role of Adenosine A2A Receptor in the Regulation of Gastric Somatostatin Release

Linda Yip and Yin Nam Kwok
Journal of Pharmacology and Experimental Therapeutics May 1, 2004, 309 (2) 804-815; DOI: https://doi.org/10.1124/jpet.103.061986

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleGASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Role of Adenosine A2A Receptor in the Regulation of Gastric Somatostatin Release

Linda Yip and Yin Nam Kwok
Journal of Pharmacology and Experimental Therapeutics May 1, 2004, 309 (2) 804-815; DOI: https://doi.org/10.1124/jpet.103.061986
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • MIP3α in Progressive Renal Injury Associated with Obesity
  • A Novel Long-Acting GLP-2, HM15912, for Short Bowel Syndrome
  • H2S Overproduction and Colonic Hypomotility in DM
Show more Gastrointestinal, Hepatic, Pulmonary, and Renal

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics